Prices delayed by at least 15 minutes | Print


Hikma Pharmaceuticals PLC (HIK)

ORD SHS 10P
Sell: 1927p|Buy: 1928.5p|Change: 47.50 (2.53%)

Open 

1903p


Previous close 

1880.5p


Trade high 

1938p


Volume 

100,536


Year high 

2,222.00p


Year low 

1,614.50p


Dividend yield 

3.03%


Market capitalisation 

£4.28 bn


P/E ratio 

27.94


ISIN 

GB00B0LCW083


This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment

Share price

Dividends

PreviousLatest
Record date11/08/202322/03/2024
Ex-dividend date10/08/202321/03/2024
Payment date15/09/202303/05/2024
Amount19.88p$0.47

Performance 27/03/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Hikma Pharmaceuticals PLC+ 0.86
FTSE 100+ 0.01
More...

Company profile

Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the revenue for the company is generated from its injectables segment under which it supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue generating market followed by Middle East and North Africa, United Kingdom, Europe and the rest of the world.

Sector 

Healthcare


News

Recent trades

DateTimePriceQuantityValue (£)
28/03/202404:23:001928751,446.00
28/03/202404:23:0019288154.24
28/03/202404:23:0019288154.24
28/03/202404:22:531928.57135.00
28/03/202404:22:531928.514269.99

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.